Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HF 3917Session 2025-2026

What changed between versions

19 paragraphs changed+159 words added−6 removed

Highlighted text was added in the newer version. Struck-through text was removed.

House

19 unchanged paragraphs

Senate

Joint

Schedules

Committees

Bills

Law

Multimedia

Publications

Office of the Revisor of Statutes

Retrieve by number Document type Statutes Laws Rules Bills GO

Statutes

Laws

Rules

Court Rules

Constitution

Revisor's Office Revisor Intranet Attorney Drafting Areas Staff Directory Office Duties Publications Educational Seminars Employment Openings Order Publications

Search Law by Keyword

Bills

94th Legislature (2025 - 2026)

HF3917

Introduction

1st Engrossment

HF 3917

Introduction1st Engrossment - 94th Legislature (2025 - 2026)

Posted on 0304/0227/2026 0203:4128 p.m.

Bill Text Versions

4 unchanged paragraphs

Engrossments

Introduction PDF

Posted on 03/02/2026

1st Engrossment PDF

Posted on 03/12/2026

A bill for an act relating to health; modifying medication repository program procedures; modifying an appropriation; amending Minnesota Statutes 2024, section 151.555, subdivision 7; Laws 2025, First Special Session chapter 3, article 23, section 2, subdivision 12.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

13 unchanged paragraphs

Section 1.

Minnesota Statutes 2024, section 151.555, subdivision 7, is amended to read:

Subd. 7.

Standards and procedures for inspecting and storing donated drugs and supplies.

(a) A pharmacist or authorized practitioner who is employed by or under contract with the central repository or a local repository shall inspect all donated drugs and supplies before the drug or supply is dispensed to determine, to the extent reasonably possible in the professional judgment of the pharmacist or practitioner, that the drug or supply is not adulterated or misbranded, has not been tampered with, is safe and suitable for dispensing, has not been subject to a recall, and meets the requirements for donation. If a local repository receives drugs and supplies from the central repository, the local repository does not need to reinspect the drugs and supplies.

(b) The central repository and local repositories shall store donated drugs and supplies in a secure storage area under environmental conditions appropriate for the drug or supply being stored. Donated drugs and supplies may not be stored with nondonated inventory.

(c) The central repository and local repositories shall dispose of all drugs and medical supplies that are not suitable for donation in compliance with applicable federal and state statutes, regulations, and rules concerning hazardous waste.

(d) In the event that controlled substances or drugs that can only be dispensed to a patient registered with the drug's manufacturer are shipped or delivered to a central or local repository for donation, the shipment delivery must be documented by the repository and returned immediately to the donor or the donor's representative that provided the drugs.

(e) Each repository must develop drug and medical supply recall policies and procedures. If a repository receives a recall notification, the repository shall destroy all of the drug or medical supply in its inventory that is the subject of the recall and complete a record of destruction form in accordance with paragraph (f). If a drug or medical supply that is the subject of a Class I or Class II recall has been dispensed, the repository shall immediately notify the recipient of the recalled drug or medical supply. A drug that potentially is subject to a recall need not be destroyed if its packaging bears a lot number and that lot of the drug is not subject to the recall. If no lot number is on the drug's packaging, it must be destroyed.

(f) A record of destruction ofnew text begin accepted new text end donated drugs and supplies that are not dispensed under subdivision 8deleted text begin , are subject to a recall under paragraph (e), or are not suitable for donationdeleted text end new text begin or are subject to a recall under paragraph (e) new text end shall be maintained by the repository for at least two years. deleted text begin For each drug or supply destroyed,deleted text end The record shall include the following information:

(1) the date of destruction;

(2) the name, strength, and quantity of the drug destroyed; and

(3) the name of the person or firm that destroyed the drug.

No other record of destruction is required.

Sec. 2.

Laws 2025, First Special Session chapter 3, article 23, section 2, subdivision 12, is amended to read:

Subd. 12.

Board of Pharmacy

Appropriations by Fund

General

937,000

937,000

State Government Special Revenue

6,280,000

6,280,000

Medication Repository Program. $450,000 in fiscal year 2026 and $450,000 in fiscal year 2027 are from the general fund for the medication repository program to purchase prescription drugs under Minnesota Statutes, section 151.555, subdivision 6, paragraph (g)new text begin , and for other costs of administering the central repository, including but not limited to costs related to mail-order dispensing and developing delivery infrastructure new text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment. new text end

Historical Information

14 unchanged paragraphs

Employment/Internships

Visiting the Capitol

Accessibility

Frequently Asked Questions

Who Represents Me?

House Members

Senators

Contact a legislative librarian:

(651) 296-8338 or Email

Phone Numbers

Submit website comments

House News

Senate News

MyBills

Email Updates & RSS Feeds

Back to the full text